跳至主要内容
临床试验/IRCT20240702062304N1
IRCT20240702062304N1招募中3 期

Effect of Omega-3 supplementation on serum level of interferon-gamma in patients with multiple sclerosis

Abadan University of Medical Sciences0 个研究点目标入组 60 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 85 years(—)
性别
All

入选标准

  • Patients with MS (diagnosis of MS based on McDonald's criteria)
  • Age 18 to 85 years
  • All types of MS (relapsing-remitting and progressive types)
  • Treated with MS course-modifying drugs at a fixed dose for 6 months before study enrollment

排除标准

  • Participants in other trials except the present clinical trial
  • Recurrence or treatment with corticosteroids in the last month
  • Simultaneous treatment with antibiotics and antihypertensive drugs
  • Other acute or severe diseases except MS
  • Current or past history of ventricular arrhythmia
  • A general health condition that interferes with participation in the study

研究者

发起方
Abadan University of Medical Sciences

相似试验

Effect of Omega-3 supplementation in patients with... | 临床试验